Mara G. Beveridge, MD

Article

Cyclosporine for Recalcitrant Bullous Pemphigoid Induced by Nivolumab Therapy for Malignant Melanoma

Author:

Mara G. Beveridge, MD

Bullous pemphigoid is a rare dermatologic immune-related adverse event that can occur secondary to anti–programmed death receptor 1 therapy.

• Read More